In Thursday’s trading session on the BSE, shares of Sun Pharmaceutical Industries declined by 5%, reaching the day’s low of Rs 1,467. This drop occurred despite the company reporting a 34% year-on-year (YoY) increase in its Q4 profit to Rs 2,654.6 crore, with revenue rising by 10.1% YoY to Rs. 11,813 crore in Q4FY24.
RIL vs Airtel: Hemang Jani explains how to approach both
Elon Musk’s SpaceX plans to enter India’s telecom sector with Starlink, intensifying competition between Bharti Airtel and Reliance. Market expert Hemang Jani suggests Reliance offers